pharmaphorum January 11, 2024
Facing a sharp rise in the number of syphilis cases, the FDA has authorised the importation from France of a life-saving drug for the sexually transmitted infection (STI) that is in short supply in the domestic market.
The US regulator has cleared the way for imports of Laboratoires Delbert’s Extencilline (benzathine benzylpenicillin), a long-acting form of penicillin that has been used for decades to treat syphilis in Europe, but has never been approved in the US.
Extencilline will be used as an alternative to Pfizer’s FDA-approved product Bicillin L-A, another long-acting product based on the same active ingredient that has been subject to shortages in the US and other countries worldwide since the middle of last year.
According to the...
Today's Sponsors
Today's Sponsor